Back to homepageSmaltis supports the research, identification and development of your ingredients and finished products designed to maintain or improve skin health. To successfully carry out your projects, rely on our experts to accompany your developments, from the research phases through tests on volunteers.
Your needs
In the framework of the development of your active ingredients or formulas, you are seeking customized in vitro solutions in microbiology and molecular biology to support your projects in the development and enhancement of personal care and hygiene products. Smaltis is the ideal company to meet your needs, given its scientific expertise and tailored approach.
Your products
- Prebiotics
- Probiotics
- Postbiotics
- Preservatives
- Plant extracts
- Active ingredients of various kinds
- Finished care or hygiene products
The approaches you work on
The products you develop can act on skin health by maintaining the cutaneous microbial balance of each individual, targeting harmful strains, rebalancing microbial dysbiosis, or protecting a formula against external contamination.
Our expertises
Our offer
At what stage are you?
| DEVELOPMENT STAGES |
1
RESEARCH AND SELECTION |
2
IN VITRO OBJECTIVATION |
3
BIOPROCESSES |
4
CLINICAL TESTS |
| YOUR OBJECTIVES |
Optimized screening of candidates |
Selection of the most promising candidates and anticipation of their clinical effects |
Optimizing processes using strains |
Assessment of the impact of a product on the balance of skin microbiota |
| OUR SERVICES |
Characterization of products in terms of functionality and safety |
Preclinical efficacy studies, |
Support for bioprocess optimization, |
Skin swabbing and standardized processing of samples, |
Why choose Smaltis?
Our services enable you to supply, enhance, and secure your data within a rigorous scientific framework, guiding you in demonstrating the efficacy of your products and identifying claims. Engage with a specialized team skilled in the manipulation of microorganisms, using diverse models for an optimized selection of your candidates, and delivering scientifically accurate and validated results, including microbiome studies on volunteers.
Get in touch!
Sophie MAC-MARY
CEO
SKINEXIGENCE
Smaltis is a laboratory that set up in the same building as our company, Skinexigence, from its inception. The proximity of our offices and the identification of a very interesting collaboration opportunity allowed us to quickly initiate a partnership to meet the growing demand from our clients for studies on the skin microbiota of volunteers. Specialized in the evaluation of the effectiveness of dermo-cosmetic products, it was only natural that we turned to Smaltis to provide our clients with expertise in the study of skin flora. For these studies, Smaltis performs skin sampling on our volunteers, sample preparation, and metagenomic analyses. The development of a very rigorous and calibrated protocol enables them to access relevant and reliable information regarding the evolution or not of the skin microbiota of a subject, in relation to the clinical parameters we observe.
Clara LEANDRO
Head of Infection
TECHNOPHAGE
The advancement of Technophage's therapeutic pipeline products has received crucial support from SMALTIS in the scope of genetic modification of bacterial strains. Throughout this collaborative effort, the SMALTIS scientific team has demonstrated remarkable commitment to resolving various technical challenges, successfully aligning with our objective of acquiring a set of strains for our internal utilization, all within the stipulated timeline.
Eric ROBINET
Founder and President
LYMPHOBANK
Specialized in the production of cell banks from blood, for research and patient use, we needed to rely on a microbiology company to ensure the absence of contamination in our products from the start of our preparations. Established at the time in the premises of the EFS, it was only natural that we turned to Smaltis, located a few steps from our laboratories. Their work approach and the reliability of their results were exactly what we were looking for, and for several years now, we have entrusted them with all our microbiological analyses. The growth of our respective companies led us to look for new premises... and it is with pleasure that we took over the premises of Smaltis, who then moved into the building just across the street! It is important to have Smaltis in our network of reliable partners with common values, to contribute to the improvement of health!
Maxime GUALTIERI
CSO
NOSOPHARM
As part of our anti-infective molecule developments, we have repeatedly sought the expertise of the Smaltis team for cloning and construction of specific mutants. The services provided by Smaltis have notably contributed to our study describing and characterizing new mechanisms of resistance to Odilorhabdines in Klebsiella pneumoniae, which was published in 2021. We know that we can rely on their know-how and expert scientific advice for our future developments.